MAPT and red-green color blindness: Based on this tau-histopathology, several clinical phenotypes of CBD may evolve beside the most frequent syndrome CBS.2 This complex and highly variable clinical presentation underlines the challenge to accurately diagnose CBD in a living patient and develop specific diagnostic criteria.